Oshiro, Ayano Imanaga, Naoya Koizumi, Hideki
Published in
American Journal of Ophthalmology Case Reports
Purpose To report a case of branch retinal vein occlusion (BRVO) in which rapid formation of macular pucker was observed after an intravitreal ranibizumab (IVR) injection. Observations A 66-year-old patient was referred to our department for the treatment of macular edema (ME) secondary to BRVO in the left eye. On the initial visit, widespread reti...
Schwartz, Roy Warwick, Alasdair Olvera-Barrios, Abraham Pikoula, Maria Lee, Aaron Y Denaxas, Spiros Taylor, Paul Egan, Catherine Chakravarthy, Usha Lip, Peck Lin
...
Published in
Ophthalmology. Retina
Management of neovascular age-related macular degeneration (nAMD) has evolved over the last decade with several treatment regimens and medications. This study describes the treatment patterns and visual outcomes over 10 years in a large cohort of patients. Retrospective analysis of electronic health records from 27 National Health Service secondary...
Khurana, Rahul N Kunimoto, Derek Yoon, Young Hee Wykoff, Charles C Chang, Andrew Maturi, Raj K Agostini, Hansjürgen Souied, Eric Chow, David R Lotery, Andrew J
...
Published in
Ophthalmology
To report the 2-year efficacy and safety of abicipar every 8 weeks and quarterly (after initial doses) compared with monthly ranibizumab in patients with treatment-naïve neovascular age-related macular degeneration (nAMD). Two multicenter, randomized, phase 3 clinical trials with identical protocols (CEDAR and SEQUOIA). Analyses used pooled trial d...
Schworm, Benedikt Luft, Nikolaus Keidel, Leonie F. Kreutzer, Thomas C. Herold, Tina R. Priglinger, Siegfried G. Siedlecki, Jakob
Published in
BMC Ophthalmology
BackgroundTo investigate the diagnostic value of choroidal thickness in the definition of pachychoroid neovasculopathy (PNV), especially in eyes treated with anti-vascular endothelial growth factor (VEGF) therapy.MethodsTwenty-two consecutive eyes of 11 patients with uni- or bilateral PNV were analyzed. Anti-VEGF treatment was correlated with chang...
Zola, Marta D'Alessandro, Elisa Sherif, Mohamed Nguyen, Audrey De Azevedo, Dominique Haeller, Céline Forestier, Edwige Mantel, Irmela
Published in
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
To assess the influence of time interval since last injection and time from baseline on central retinal thickness (CRT) in neovascular age-related macular degeneration (nAMD) with fluid refractory to monthly anti-VEGF treatment. This retrospective study included nAMD eyes with incomplete response to anti-VEGF defined by the presence of intra- or su...
Ranjan, Ratnesh Verghese, Shishir Salian, Romit Manayath, George J Saravanan, Veerappan R Narendran, Venkatapathy
Published in
American journal of ophthalmology case reports
To describe the multimodal imaging findings and treatment outcomes in choroidal neovascularization secondary to Choroideremia. A 13-year-old male presented with reduced visual acuity in the left eye. He gave a history of nyctalopia. His best-corrected visual acuity (BCVA) was 20/20 in the right eye and 20/40 in the left eye. Based on multimodal ima...
Ni, Weiyi Liu, Jia Jiang, Yawen Wu, Jing
Published in
BMC Ophthalmology
BackgroundClinical trials in China have demonstrated that ranibizumab can improve the clinical outcomes of branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). However, no economic evaluation of ranibizumab has been conducted among Chinese patient population.MethodsTo provide insights into the economic profile of ranibizu...
Xavier, Tessy Pallikara, Swetha Saji, Neha Radhakrishnan, Natasha Menon, Krishnakumar N Pillai, Gopal S
Published in
Indian Journal of Ophthalmology
Purpose: Identification of nonresponders prior to anti-vascular endothelial growth factor (anti-VEGF) therapy would help in the judicious clinical management of diabetic macular edema (DME) patients. Thus, a systematic study was initiated to identify nonresponding DME patient population undergoing ranibizumab treatment to figure out additional infl...
Anderson, William J. da Cruz, Natasha Ferreira Santos Lima, Luiz Henrique Emerson, Geoffrey G. Rodrigues, Eduardo Büchele Melo, Gustavo Barreto
Published in
International Journal of Retina and Vitreous
BackgroundIntraocular inflammation is an uncommon but potentially vision-threatening adverse event related to anti-VEGF therapy. This is of increasing importance given both the volume of injections performed, as well as the increased prevalence of inflammation seen with newer anti-VEGF agents. Brolucizumab, the newest anti-VEGF agent, has been asso...
Horner, Faye Lip, Peck Lin Mohammed, Bashar R Fusi-Rubiano, William Gokhale, Eesha Mushtaq, Bushra Chavan, Randhir
Published in
Clinical Ophthalmology (Auckland, N.Z.)
Purpose To compare and report the 2-year treatment outcomes from 3 different anti-VEGF treatment regimens in treating neovascular aged-related macular degeneration (nAMD): Ranibizumab pro re nata (Ranibizumab-PRN); Ranibizumab treat and extend (Ranibizumab-T&E); Aflibercept fixed first year dosing (7 injections) with treat and extend in subsequent ...
